Department of Urology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Department of Urology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Urol Oncol. 2022 Jul;40(7):346.e17-346.e26. doi: 10.1016/j.urolonc.2022.02.022. Epub 2022 Apr 7.
The incidence and outcomes of bladder cancer (BCa) have apparent sex differences. Various observational studies have demonstrated that the age of menarche might be associated with female BCa. To explore this relationship, a meta-analysis and systematic review were performed based on available studies.
A systematic search was performed in PubMed, Embase, and Web of Science for studies published up to October 1, 2021. Two reviewers independently extracted related data between age of menarche and BCa risk from the included studies. The Newcastle-Ottawa quality assessment scale was applied to evaluate the quality of the studies. The relative risk (RR) ratio and its 95% confidence interval (CI) were then calculated.
A total of 12 studies containing 3,719 BCa cases and 1,350,207 women, were included in this meta-analysis. The pooled data showed that the age of menarche was not significantly associated with BCa risk (RR = 0.96, 95% CI: 0.85-1.08), although the evidence was of moderate quality. Similar results were observed in case-control (RR = 1.33, 95% CI = 0.77-2.21) and cohort studies (RR = 0.95, 95% CI = 0.84-1.07). Moreover, subgroup analyses based on study quality, population, exposure assessment, and several potential important confounders and risk factors revealed similar results. No evidence of publication bias and significant heterogeneity was found among these studies. Furthermore, a random-effects dose-response meta-regression model was established, which revealed negative results.
Our findings suggested that the age of menarche was not associated with BCa risk in women. However, these findings needed to be further confirmed given the limitations and potential biases.
膀胱癌(BCa)的发病率和结局存在明显的性别差异。各种观察性研究表明,初潮年龄可能与女性 BCa 有关。为了探讨这种关系,我们基于现有研究进行了荟萃分析和系统评价。
我们在 PubMed、Embase 和 Web of Science 中进行了系统性检索,检索截至 2021 年 10 月 1 日发表的研究。两位审查员独立从纳入研究中提取初潮年龄与 BCa 风险之间的相关数据。我们应用纽卡斯尔-渥太华质量评估量表来评价研究质量。然后计算相对风险(RR)比及其 95%置信区间(CI)。
本荟萃分析共纳入 12 项研究,包含 3719 例 BCa 病例和 1350207 名女性。汇总数据显示,初潮年龄与 BCa 风险无显著相关性(RR=0.96,95%CI:0.85-1.08),但证据质量为中等。病例对照研究(RR=1.33,95%CI=0.77-2.21)和队列研究(RR=0.95,95%CI=0.84-1.07)也得到了相似的结果。此外,基于研究质量、人群、暴露评估以及几个潜在重要混杂因素和危险因素的亚组分析也得出了相似的结果。这些研究中未发现发表偏倚和显著的异质性。此外,我们建立了一个随机效应剂量-反应荟萃回归模型,结果为阴性。
我们的研究结果表明,初潮年龄与女性 BCa 风险无关。然而,鉴于存在的局限性和潜在偏倚,这些发现需要进一步证实。